Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have demonstrated in laboratory animals that a compound derived from a common plant can be used to treat and prevent the most widespread form of cancer in people

18 Oct 2004

Fruit and vitamin C intake are likely to be useful for the prevention of stomach cancer

The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study was initiated to test the effect of vitamin supplementation on the prevention of lung and other cancers.

18 Oct 2004

Vitamin E's status as a super supplement questioned

Over the past decade, vitamin E has become one of the top-selling supplements in the United States, in part because research released in the early- to mid-1990s suggested that taking vitamin E supplements might protect against heart disease, boost the immune system and reduce the risk of macular degeneration.

14 Oct 2004

Black men have better sexual and urinary function than white men after prostate cancer surgery

Five years after surgery for prostate cancer, African-American men reported better sexual and urinary function than non-Latino white men-yet they were also more dissatisfied with problems related to their sexual function

13 Oct 2004

Paroxetine is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer

A new antidepressant medication is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer, Mayo Clinic researchers report in the October issue of Mayo Clinic Proceedings.

12 Oct 2004

Prostate cancer patients who no longer respond to hormone therapy may benefit from a combination of docetaxel and estramustine

Prostate cancer patients whose cancer has spread to other parts of the body and who no longer respond to hormone therapy may benefit from a combination of the cancer drugs docetaxel and estramustine, according to a new study published in the Oct. 8 issue of the New England Journal of Medicine.

8 Oct 2004

Men with advanced, incurable prostate cancer can benefit from docetaxel

An international study led by a Canadian researcher shows that men with advanced, incurable prostate cancer can survive an average of three months longer and face less symptoms when offered a new treatment for prostate cancer.

7 Oct 2004

Call for UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas

Speaking today at a workshop on 'Cancer treatment: a priority for patients in Europe', cancer specialists and representatives of cancer patients called on the UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas during their Presidencies of the EU in 2005.

7 Oct 2004

Breast cancer drug Taxotere extends life of prostate cancer patients

Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy

6 Oct 2004

$10 million to establish a multidisciplinary research program in cancer nanotechnology

The National Institutes of Health (NIH) has awarded scientists from Emory University and the Georgia Institute of Technology two new collaborative research grants, totaling nearly $10 million, to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

6 Oct 2004

Study suggests that radiation oncologists can and should be more aggressive in their treatment of prostate cancer

Increasing the radiation dose delivered by highly conformal external beam radiation to men suffering from early stage prostate cancer shows an advantage in terms of increased disease-free survival rates

5 Oct 2004

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

The National Institutes of Health (“NIH”) has selected The Burnham Institute to develop a national resource for medical researchers to be known as the “Center on Proteolytic Pathways”.

4 Oct 2004

Lycopene may be able to inhibit the growth of prostate tumours

A study by Dutch and German researchers has provided evidence that lycopene may be able to inhibit the growth of prostate tumours and that its effect may be enhanced if it is combined with vitamin E.

30 Sep 2004

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.

30 Sep 2004

Male smokers needed for study to investigate new method of improving selenium intake

Around 200 men – including men who smoke – are being sought by researchers in Adelaide, South Australia to take part in a new study aimed at preventing cancer and other health problems.

30 Sep 2004

Black men in the United States are significantly less likely to be screened for prostate cancer

Although black men in the United States are more likely than white men to be diagnosed with advanced prostate cancer and have a two-fold greater risk of dying from it, they are significantly less likely to be screened for prostate cancer

29 Sep 2004

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.

28 Sep 2004

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Fruit and vitamin C intake are likely to be useful for the prevention of stomach cancer

Vitamin E's status as a super supplement questioned

Black men have better sexual and urinary function than white men after prostate cancer surgery

Paroxetine is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer

Prostate cancer patients who no longer respond to hormone therapy may benefit from a combination of docetaxel and estramustine

Men with advanced, incurable prostate cancer can benefit from docetaxel

Call for UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas

Breast cancer drug Taxotere extends life of prostate cancer patients

$10 million to establish a multidisciplinary research program in cancer nanotechnology

Study suggests that radiation oncologists can and should be more aggressive in their treatment of prostate cancer

New national resource for medical researchers to be known as the Center on Proteolytic Pathways

Lycopene may be able to inhibit the growth of prostate tumours

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

Male smokers needed for study to investigate new method of improving selenium intake

Black men in the United States are significantly less likely to be screened for prostate cancer

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

New hope for patients suffering hormone therapy resitant prostate cancer

Prostate cancer treatment leads to declines in sexual and urinary function

Elderly African American men are less likely to get tested for prostate cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in